Dimethylamine

Dimethylamine

SCHEMBL5206984

CCOC(=O)Cc1c(Cl)ccc2ccc(CN(C)C)cc12.CNC

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.39
LMNA P02545 1/20 0.39
TSHR P16473 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CYP4F2 P78329 1/20 0.38
CYP4A11 Q02928 1/20 0.38
MAPT P10636 3/20 0.38
L3MBTL1 Q9Y468 3/20 0.36
POLB P06746 2/20 0.36
TRPV1 Q8NER1 1/20 0.36
KMT2A Q03164 3/20 0.36
PRKCB P05771 2/20 0.36
PRKCA P17252 2/20 0.36
PRKCH P24723 2/20 0.36
PRKCE Q02156 2/20 0.36
PRKCQ Q04759 2/20 0.36
PRKCD Q05655 2/20 0.36
HTT P42858 2/20 0.35
ALOX15 P16050 1/20 0.35
CRHBP P24387 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL989779 0.96 CYP4F2 (0.40) KDM4ELMNATSHRSMN1; SMN2CYP4F2
SCHEMBL3588780 0.88 CYP4F2 (0.40) KDM4ELMNATSHRSMN1; SMN2CYP4F2
SCHEMBL992003 0.79 SLC6A4 (0.46) TRPV1PRKCBPRKCAPRKCHPRKCE
SCHEMBL991440 0.78 KDM4E (0.43) KDM4ELMNAMAPTTRPV1KMT2A
SCHEMBL2788047 0.78 TSHR (0.42) KDM4ELMNATSHRSMN1; SMN2CYP4F2
SCHEMBL1028100 0.76 HDAC1 (0.34) KDM4ELMNACYP4F2CYP4A11MAPT
SCHEMBL989998 0.76 KDM4E (0.41) KDM4ELMNASMN1; SMN2MAPTL3MBTL1
SCHEMBL991313 0.76 PTGS2 (0.54) KDM4ETSHRMAPTL3MBTL1ALDH1A1
SCHEMBL27658425 0.75 RAD52 (0.44) TSHRCYP4F2CYP4A11TRPV1PRKCB
SCHEMBL991950 0.74 ALOX15 (0.40) KDM4ELMNATSHRSMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1745037-A1 INDOLYLMALEIMIDE DERIVATIVES AS PKC INHIBITORS Novartis AG (CH) 2007-01-24 EP disclosed
WO-2005068455-A1 INDOLYLMALEIMDE DERIVATIVES AS PKC INHIBITORS NOVARTIS AG (CH) 2005-07-28 WO disclosed